Key result
Acute Montmorency tart cherry increases peak sprint power ~10% and total work versus placebo.
Why the study?
The effects of acute Montmorency tart cherry consumption on nitric oxide biomarkers and exercise performance in trained cyclists were unclear.
Does acute ingestion of Montmorency tart cherry improve exercise performance and lower blood pressure in trained cyclists?
RCT
Does acute ingestion of Montmorency tart cherry improve exercise performance and lower blood pressure in trained cyclists?
Absolute Event Rate: 363% vs 330%
p-value: p=< .05
Acute supplementation with Montmorency tart cherry may lower systolic blood pressure and improve end-sprint exercise performance in trained cyclists.
Acute Montmorency tart cherry may enhance sprint performance in trained cyclists; extends RCT evidence on acute ergogenic effects.
59.0 ± 7.0 mL/kg/min) acutely ingested 30 mL of either MC or PLA following dietary restrictions of polyphenol-rich compounds and completed 6-minutes moderate- and severe-intensity cycling bouts 1.5 hour post-ingestion on 2 occasions for each experimental condition. The severe-intensity cycling test was continued to exhaustion on 1 occasion and immediately followed by a 60-seconds all-out sprint on the other occasion. Blood pressure, pulse wave measures, tissue oxygenation index, and plasma nitrite concentration were assessed pre- and 1.5 hour post-ingestion. Time to exhaustion was not different between conditions (P > .05), but peak power over the first 20 seconds (363 ± 42 vs 330 ± 26 W) and total work completed during the 60-seconds all-out sprint (21 ± 3 vs 19 ± 3 kJ) were 10% higher in the MC trial compared to the PLA trial (P < .05). Systolic blood pressure was 5 ± 2 mm Hg lower 1.5 hour post-MC supplementation compared to PLA supplementation (P < .05). There were no differences in pulse wave measures, plasma nitrite concentration, or tissue oxygenation between the MC and PLA trials (P > .05). These results suggest that acute supplementation with MC can lower blood pressure and improve some aspects of exercise performance, specifically end-sprint performance, in trained cyclists.
No takes yet. Share an insight, caveat, or question.
Keane et al. (2018) conducted an RCT in trained cyclists. Montmorency tart cherry (MC) vs. Placebo (PLA) was evaluated on Peak power over the first 20 seconds of a 60-second all-out sprint (W) (p=< .05). Acute supplementation with Montmorency tart cherry increased peak power over the first 20 seconds (363 vs 330 W) and total work during a 60-second sprint compared to placebo (P < .05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: